中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

乙型肝炎相关慢加急性肝衰竭诱因的研究进展

郑颖 李用国

引用本文:
Citation:

乙型肝炎相关慢加急性肝衰竭诱因的研究进展

DOI: 10.3969/j.issn.1001-5256.2017.09.039
详细信息
  • 中图分类号: R512.62;R575.3

Research advances in predisposing factors for acute-on-chronic hepatitis B liver failure

  • 摘要: 我国大部分慢加急性肝衰竭的病因源于HBV,所以乙型肝炎相关慢加急性肝衰竭是目前面临的最具挑战性的公共卫生问题之一。特别是随着长期服用核苷和核苷酸类药物用药时间的延长、各种药物的滥用以及经济文化多样化引起的大众饮酒习惯的改变,导致乙型肝炎相关慢加急性肝衰竭的诱因趋于复杂化。分析这种现象发生的原因,有助于在临床早期预防乙型肝炎相关慢加急性肝衰竭的发生,从而降低病死率。

     

  • [1]ARROYO V, MOREAU R, JALAN R, et al.Acute-on-chronic liver failure:a new syndrome that will re-classify cirrhosis[J].JHepatol, 2015, 62 (1) :131-143.
    [2]BERNAL W, JALAN R, QUAGLIA A, et al.Acute-on-chronic liver failure[J].Lancet, 2015, 386 (10003) :1576-1587.
    [3]KE WM, YE YN, HUANG S.Discriminate function for prognostic indexes and probability of death in chronic severe hepatitis B[J].JGastroenterol, 2003, 38 (9) :861-864.
    [4]YOU SL, RONG YH, ZHU B, et al.Changing etiology of liver failure in 3, 916 patients from northern China:a 10-year survey[J].Hepatol Int, 2013, 7 (2) :714-720.
    [5]ZENG QL, DAI M.Influencing factors for the prognosis of acuteon-chronic hepatitis B liver failure[J].J Med Theor&Pract, 2015, 28 (8) :1051-1052. (in Chinese) 曾庆朗, 戴明.乙型肝炎慢加急性肝衰竭预后的影响因素分析[J].医学理论与实践, 2015, 28 (8) :1051-1052.
    [6]OHNISHI H, SUGIHARA J, MORIWAKI H, et al.Acute-onchronic liver failure[J].Ryoikibetsu Shokogun Shirizu, 1995, 7:217-219.
    [7]SARIN SK, KEDARISETTY CK, ABBAS Z, et al.Acute-onchronic liver failure:consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) 2014[J].Hepatol Int, 2014, 8 (4) :453-471.
    [8]OLSON JC, WENDON JA, KRAMER DJ, et al.Intensive care of the patient with cirrhosis[J].Hepatology, 2011, 54 (5) :1864-1872.
    [9]Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association, Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association.Diagnostic and treatment guidelines for liver failure (2012 version) [J].J Pract Hepatol, 2013, 16 (3) :210-221. (in Chinese) 中华医学会感染学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2012年版) [J].实用肝脏病杂志, 2013, 16 (3) :210-221.
    [10]JALAN R, GINES P, OLSON JC, et al.Acute-on chronic liver failure[J].J Hepatol, 2012, 57 (6) :1336-1348.
    [11]LEVY MM, FINK MP, MARSHALL JC, et al.2001 SCCM/ES-ICM/ACCP/ATS/SIS international sepsis definitions conference[J].Crit Care Med, 2003, 31 (4) :1250-1256.
    [12]OLSON JC, KAMATH PS.Acute-on-chronic liver failure:concept, natural history, and prognosis[J].Curr Opin Crit Care, 2011, 17 (2) :165-169.
    [13]SARIN SK, CHOUDHURY A.Acute-on-chronic liver failure:terminology, mechanisms and management[J].Nat Rev Gastroenterol Hepatol, 2016, 13 (3) :131-149.
    [14]JIANG HY, XIAO JM.Clinical survey and analysis on unauthorized drug drug withdrawal induced relapse in chronic viral hepatitis patients[J].Chin Nurs Res, 2014, 28 (8) :2770-2771. (in Chinese) 江海英, 肖江民.慢性乙型病毒性肝炎病人擅自停药致病情复发的临床分析[J].护理研究, 2014, 28 (8) :2770-2771.
    [15]ZHENG Y, CHEN S, LI YG, et al.The percentage and severity of HBV-related acute-on-chronic liver failure patients result from irregular medication of nucleos (t) ide analogues[C].Abstracts of the 26th Annual Conference of APASL.China, 2017.
    [16]CHEN Y, LI SS, DUAN ZP.Research advances in acute-onchronic liver failure[J].Beijing Med J, 2015, 37 (9) :816-819. (in Chinese) 陈煜, 李珊珊, 段钟平.慢加急性肝衰竭的研究进展[J].北京医学, 2015, 37 (9) :816-819.
    [17]ZHANG MY, ZHANG S, ZHOU BT, et al.Hepatitis B virus reactivation and prophylaxis[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2017, 11 (1) :4-9. (in Chinese) 张梦阳, 张硕, 周宝桐, 等.乙型肝炎病毒再激活及其预防性治疗[J/CD].中华实验和临床感染病杂志:电子版, 2017, 11 (1) :4-9.
    [18]AOKI J, KOWAZAKI Y, OHTSUKI T, et al.Kinetics of peripheral hepatitis B virus-specific CD8+T cells in patients with onset of viral reactivation[J].J Gastroenterol, 2013, 48 (6) :728-737.
    [19]ZHANG Z, ZHANG JY, WHERRY EJ, et al.Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B[J].Gastroenterology, 2008, 134 (7) :1-3.
    [20]WAN ZH, WU YC, YI J, et al.Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure[J].PLo SOne, 2015, 10 (1) :e0116968.
    [21]LPEZ-VELZQUEZ JA, CHVEZ-TAPIA NC, PONCIANO-RODRGUEZ G, et al.Bilirubin alone as a biomarker for short-term mortality in acute-on-chronic liver failure:an important prognostic indicator[J].Ann Hepatol, 2014, 13 (1) :98-104.
    [22]LI F, YAN T, LI K, et al.Plasma cell-free DNA for predicting outcomes of patients with HBV-related acute-on-chronic liver failure:a pilot study[J].J South Med Univ, 2014, 34 (2) :147-152.
    [23]WANG YL, LI H.Related factors affecting the prognosis of patients with hepatitis B and liver failure[J].Chin J Gastroenterol Hepatol, 2014, 23 (10) :1191-1194. (in Chinese) 王艳丽, 黎环.乙型肝炎肝衰竭患者预后影响因素研究[J].胃肠病学和肝病学杂志, 2014, 23 (10) :1191-1194.
    [24]KONSTANTINA S, HANNE P, EMMA N, et al.Predictors of mortality among patients with compensated and decompensated liver cirrhosis:the role of bacterial infections and infection-related acuteon-chronic liver failure[J].Scand J Gastroenterol, 2015, 50 (7) :1-9.
    [25]RG M, MONTAGNESE S, JALAN R.Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-onchronic liver failure[J].J Hepatol, 2015, 62 (2) :437-447.
    [26]SHI X, ZHU P, YAN G, et al.Clinical characteristics and longterm outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure[J].J Viral Hepat, 2016, 23 (11) :920-929.
    [27]KE WM.Establishment of a severity evaluation system for acuteon-chronic hepatitis B liver failure and its clinical application[J].J Clin Intern Med, 2014, 31 (8) :519-523. (in Chinese) 柯伟民.一种适用于乙型肝炎慢加急性肝衰竭严重性评估系统的建立以及临床应用解读[J].临床内科杂志, 2014, 31 (8) :519-523.
    [28]CHALASANI NP, HAYASHI PH, BONKOVSKY HL, et al.ACG clinical guideline:the diagnosis and management of idiosyncratic drug-induced liver injury[J].Am J Gastroenterol, 2014, 109 (7) :950-966.
    [29]TIAN MM, WANG XB, LI YR, et al.Clinical features and relative prognosis factors of 56 patients with drug-induced liver failure[J].Prog Mod Biomed, 2013, 13 (30) :5929-5933. (in Chinese) 田梅梅, 王宪波, 李蕴铷, 等.药物性肝衰竭临床特点及预后有关因素分析[J].现代生物医学进展, 2013, 13 (30) :5929-5933.
    [30]FONTANA RJ, HAYASHI PH, GU J, et al.Idiosyncratic druginduced liver injury is associated with substantial morbidity and mortality within 6 months from onset[J].Gastroenterology, 2014, 147 (1) :96-108.
    [31]DUAN Y, XING HC, WANG XM, et al.Clinical characteristics and prognosis of drug-induced subacute liver failure[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition, 2012, 6 (3) :217-220. (in Chinese) 段英, 邢卉春, 王笑梅, 等.药物性亚急性肝衰竭临床特点及预后[J/CD].中华实验和临床感染病杂志:电子版, 2012, 6 (3) :217-220.
    [32]REUBEN A, KOCH DG, LEE WM, et al.Drug-induced acute liver failure:results of a U.S.multicenter, prospective study[J].Hepatology, 2010, 52 (6) :2065-2076.
    [33]ZHAO ZG, HAN T, GAO YT, et al.Causes and clinical outcomes of acute-on-chronic liver failure in patients with hepatitis B virus infection:an analysis of 289 cases[J].World Chin J Dig, 2009, 17 (31) :3269-3272. (in Chinese) 赵振刚, 韩涛, 高英堂, 等.乙型肝炎患者并发慢加急性肝衰竭诱因及转归分析289例[J].世界华人消化杂志, 2009, 17 (31) :3269-3272.
    [34]MOREAU R, JALAN R, GINES P, et al.Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J].Gastroenterology, 2013, 144 (7) :1426-1437.
    [35]PILMIS B, PUEL A, LORTHOLARY O, et al.New clinical phenotypes of fungal infections in special hosts[J].Clin Microbiol Infect, 2016, 22 (8) :681-687.
    [36]KUMAR ACHARYA S, KUMAR SHARMA P, SINGH R, et al.Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death[J].J Hepatol, 2007, 46 (3) :387-394.
    [37]SARAVANABALAJI S, TRIPATHY AS, DHOOT RR, et al.Viral load, antibody titers and recombinant open reading frame 2 protein-induced TH1/TH2 cytokines and cellular immune responses in self-limiting and fulminant hepatitis E[J].Intervirology, 2009, 52 (2) :78-85.
    [38]CHOI YS, LEE J, LEE HW, et al.Liver injury in acute hepatitis A is associated with decreased frequency of regulatory T cells caused by Fas-mediated apoptosis[J].Gut, 2015, 64 (8) :1303-1313.
    [39]TRIPATHY AS, DAS R, RATHOD SB, et al.Peripheral T regulatory cells and cytokines in hepatitis E infection[J].Eur J Clin Microbiol Infect Dis, 2012, 31 (2) :179-184.
    [40]KEEFFE EB.Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?[J].Gastroenterol, 1995, 90 (2) :201-205.
    [41]ZHANG X, KE W, XIE J, et al.Comparison of effects of hepatitis E or A viral superinfection in patients with chronic hepatitis B[J].Hepatol Int, 2010, 4 (3) :615-620.
    [42]LIU FF, SU HB, WANG HF, et al.Causes of HBV-related acute-on-chronic liver failure[J].Infect Dis Info, 2010, 23 (3) :161-164. (in Chinese) 柳芳芳, 苏海滨, 王慧芳, 等.HBV相关慢加急性肝衰竭发病诱因分析[J].传染病信息, 2010, 23 (3) :161-164.
    [43]HUANG Y, GAN JH, LUO EP, et al.Inducement and prognosis of acute-on-chronic liver failure caused by hepatitis B virus:an analysis of 156 cases[J].Suzhou Univ J Med Sci, 2011, 31 (2) :265-267. (in Chinese) 黄燕, 甘建和, 罗二平, 等.乙型肝炎病毒致慢加急性肝衰竭156例诱因及预后分析[J].苏州大学学报, 2011, 31 (2) :265-267.
  • 加载中
计量
  • 文章访问数:  1941
  • HTML全文浏览量:  62
  • PDF下载量:  423
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-02-28
  • 出版日期:  2017-09-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回